Subject    :    [2017 Oct;41(5)] Effects of Lobeglitazone, a Novel Thiazolidinedione, on Bone Mineral Density in Patients with Type 2 Diabetes Mellitus over 52 Weeks
Writer KDA
Date 2018-12-03 18:28:34 Hit 777
   
Diabetes Metab J. 2017 Oct;41(5):377-385. English.
Published online Oct 24, 2017.  https://doi.org/10.4093/dmj.2017.41.5.377 
Copyright © 2017 Korean Diabetes Association
   
Effects of Lobeglitazone, a Novel Thiazolidinedione, on Bone Mineral Density in Patients with Type 2 Diabetes Mellitus over 52 Weeks
Soo Lim,1,* Kyoung Min Kim,1,* Sin Gon Kim,2 Doo Man Kim,3 Jeong-Taek Woo,4 Choon Hee Chung,5Kyung Soo Ko,6 Jeong Hyun Park,7 Yongsoo Park,8,9 Sang Jin Kim,10 Hak Chul Jang,1 and Dong Seop Choi2
1Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
2Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea.
3Department of Internal Medicine, Hallym University Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Korea.
4Department of Internal Medicine, Kyung Hee University Hospital, Kyung Hee University School of Medicine, Seoul, Korea.
5Department of Internal Medicine, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, Wonju, Korea.
6Department of Internal Medicine, Cardiovascular and Metabolic Disease Center, Inje University Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea.
7Department of Internal Medicine, Inje University Busan Paik Hospital, Inje University College of Medicine, Busan, Korea,
8Kosair Children's Hospital Research Institute, University of Louisville, Louisville, KY, USA.
9Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea.
10Department of Internal Medicine, Soon Chun Hyang University Cheonan Hospital, Soon Chun Hyang University College of Medicine, Cheonan, Korea.

Corresponding author: Dong Seop Choi. Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, 73 Inchon-ro, Seongbuk-gu, Seoul 02841, Korea. Email: cdongs@kumc.or.kr

 

*Soo Lim and Kyoung Min Kim contributed equally to this study as first authors.
 
Received March 08, 2017; Accepted May 05, 2017.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.



Abstract

Background

The aim of this multicenter, randomized, double-blind study was to examine the effect of lobeglitazone, a novel thiazolidinedione, on the changes in bone mineral density (BMD) in patients with type 2 diabetes mellitus.

Methods

A 24-week, double-blinded phase was followed by a 28-week, open-label phase, in which the placebo group also started to receive lobeglitazone. A total of 170 patients aged 34 to 76 years were randomly assigned in a 2:1 ratio to receive lobeglitazone 0.5 mg or a matching placebo orally, once daily. BMD was assessed using dual-energy X-ray absorptiometry at week 24 and at the end of the study (week 52).

Results

During the double-blinded phase, the femur neck BMD showed decreasing patterns in both groups, without statistical significance (−0.85%±0.36% and −0.78%±0.46% in the lobeglitazone and placebo groups, respectively). The treatment difference between the groups was 0.07%, which was also not statistically significant. Further, minimal, nonsignificant decreases were observed in both groups in the total hip BMD compared to values at baseline, and these differences also did not significantly differ between the groups. During the open-label phase, the BMD was further decreased, but not significantly, by −0.32% at the femur neck and by −0.60% at the total hip in the lobeglitazone group, and these changes did not significantly differ compared with the original placebo group switched to lobeglitazone.

Conclusion

Our results indicate that treatment with lobeglitazone 0.5 mg over 52 weeks showed no detrimental effect on the BMD compared to the placebo.

   
Keywords:
Bone densityDiabetes mellitus, type 2LobeglitazoneThiazolidinediones

Articles - Reviews in DMJ
No. Subject Date Hit ↓
Notice : [2017 Oct;41(5)] Generation of Insulin-Expressing Cells in Mouse Small Intestine by Pdx1, MafA, and BETA2/NeuroD [2017 Oct;41(5)] Generation of Insulin-Expressing Cells in Mouse Sma... 2018-12-03 759
Notice : [2017 Oct;41(5)] Features of Long-Standing Korean Type 2 Diabetes Mellitus Patients with Diabetic Retinopathy: A Study Based on Standardized Clinical Data [2017 Oct;41(5)] Features of Long-Standing Korean Type 2 Diabetes Me... 2018-12-03 780
Notice : [2017 Oct;41(5)] Performance of the Achutha Menon Centre Diabetes Risk Score in Identifying Prevalent Diabetes in Tamil Nadu, India [2017 Oct;41(5)] Performance of the Achutha Menon Centre Diabetes Ri... 2018-12-03 757
Notice : [2017 Oct;41(5)] Effects of Lobeglitazone, a Novel Thiazolidinedione, on Bone Mineral Density in Patients with Type 2 Diabetes Mellitus over 52 Weeks [2017 Oct;41(5)] Effects of Lobeglitazone, a Novel Thiazolidinedione... 2018-12-03 777
Notice : [2017 Oct;41(5)] Insulin Therapy for Adult Patients with Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association, 2017 [2017 Oct;41(5)] Insulin Therapy for Adult Patients with Type 2 Diab... 2018-12-03 746
Notice : [2017 Oct;41(5)] Combination Therapy of Oral Hypoglycemic Agents in Patients with Type 2 Diabetes Mellitus [2017 Oct;41(5)] Combination Therapy of Oral Hypoglycemic Agents in ... 2018-12-03 736
Notice : [2017 Oct;41(5)] Monotherapy in Patients with Type 2 Diabetes Mellitus [2017 Oct;41(5)] Monotherapy in Patients with Type 2 Diabetes Mellit... 2018-12-03 737
Notice : [2017 Oct;41(5)] Antihyperglycemic Agent Therapy for Adult Patients with Type 2 Diabetes Mellitus 2017: A Position Statement of the Korean Diabetes Association [2017 Oct;41(5)] Antihyperglycemic Agent Therapy for Adult Patients ... 2018-12-03 755
Notice : [2017 Oct;41(5)] Skeletal Muscle Thermogenesis and Its Role in Whole Body Energy Metabolism [2017 Oct;41(5)] Skeletal Muscle Thermogenesis and Its Role in Whole... 2018-12-03 748
Notice : [2017 Aug;41(4)] Factors Associated with Improved Glycemic Control by Direct-Acting Antiviral Agent Treatment in Egyptian Type 2 Diabetes Mellitus Patients with Chronic Hepatitis C Genotype 4 [2017 Aug;41(4)] Factors Associated with Improved Glycemic Control b... 2018-12-03 746
Notice : [2017 Aug;41(4)] In Vitro Effect of Fatty Acids Identified in the Plasma of Obese Adolescents on the Function of Pancreatic β-Cells [2017 Aug;41(4)] In Vitro Effect of Fatty Acids Identified in the P... 2018-12-03 727
Notice : [2017 Aug;41(4)] Depression and Mortality in People with Type 2 Diabetes Mellitus, 2003 to 2013: A Nationwide Population-Based Cohort Study [2017 Aug;41(4)] Depression and Mortality in People with Type 2 Diab... 2018-12-03 753
Notice : [2017 Aug;41(4)] Determinants of Long-Term Durable Glycemic Control in New-Onset Type 2 Diabetes Mellitus [2017 Aug;41(4)] Determinants of Long-Term Durable Glycemic Control ... 2018-12-03 717
Notice : [2017 Aug;41(4)] Effects of High-Dose α-Lipoic Acid on Heart Rate Variability of Type 2 Diabetes Mellitus Patients with Cardiac Autonomic Neuropathy in Korea [2017 Aug;41(4)] Effects of High-Dose α-Lipoic Acid on Heart Rate ... 2018-12-03 753
Notice : [2017 Aug;41(4)] Comparison of Glucose Area Under the Curve Measured Using Minimally Invasive Interstitial Fluid Extraction Technology with Continuous Glucose Monitoring System in Diabetic Patients [2017 Aug;41(4)] Comparison of Glucose Area Under the Curve Measured... 2018-12-03 728
Notice : [2017 Aug;41(4)] The Effectiveness of Green Tea or Green Tea Extract on Insulin Resistance and Glycemic Control in Type 2 Diabetes Mellitus: A Meta-Analysis [2017 Aug;41(4)] The Effectiveness of Green Tea or Green Tea Extract... 2018-12-03 715
Notice : [2017 Aug;41(4)] Unusual Suspects in the Development of Obesity-Induced Inflammation and Insulin Resistance: NK cells, iNKT cells, and ILCs [2017 Aug;41(4)] Unusual Suspects in the Development of Obesity-Indu... 2018-12-03 760
197 [2017 Jun;41(3)] Satisfaction Survey on Information Technology-Based... 2017-07-06 7,932
196 [2017 Jun;41(3)] The Effect of 12 Weeks Aerobic, Resistance, and Com... 2017-07-06 7,854
195 [2017 Jun;41(3)] Impact of Gender on the Association between Low Ser... 2017-07-06 7,795
194 [2017 Jun;41(3)] Physician-Directed Diabetes Education without a Med... 2017-07-06 7,495
193 [2017 Jun;41(3)] Knowledge, Attitude, and Practice of Iranian Intern... 2017-07-06 7,399
192 [2017 Jun;41(3)] Comparison of Antidiabetic Regimens in Patients wit... 2017-07-06 7,616
191 [2017 Jun;41(3)] Diabetes Prevention in Australia: 10 Years Results ... 2017-07-06 7,416
190 [2017 Jun;41(3)] Comprehensive Approach for Managing the Older Perso... 2017-07-06 7,095
189 [2017 Apr;41(2)] A Cutoff for Age at Menarche Predicting Metabolic S... 2017-07-06 7,068
188 [2017 Apr;41(2)] Addition of Ipragliflozin to Metformin Treatment in... 2017-07-06 7,449

목록

Gets the previous 5 pages.   Go to previous page.  [1]   2   3   4   5     Go to next page. Gets the next  5 pages.